Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Potassium and Related Disorders

Potassium and Related Disorders is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 16k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the management of hyperkalemia, particularly in patients with kidney diseases. It covers various aspects such as the use of renin-angiotensin-aldosterone system inhibitors, potassium homeostasis, and the effectiveness of treatments like sodium zirconium cyclosilicate and patiromer. Additionally, it explores the association of hyperkalemia with conditions like chronic kidney disease, heart failure, and gastrointestinal adverse events.

  • Hyperkalemia
  • Renin-Angiotensin-Aldosterone System Inhibitors
  • Potassium Homeostasis
  • Sodium Zirconium Cyclosilicate
  • Patiromer
  • Chronic Kidney Disease
  • Electrolyte Disorders
  • Gastrointestinal Adverse Events
  • Heart Failure
  • Esophageal Necrosis
Research works
16k
fractional, since 1950
In the world top 10%
1.7k
per year above
Top-10% rate
10.3%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+20%
the tick is no change
Largest producer
United States
40% of the 10 largest, 2022-now
Potassium and Related Disorders

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Potassium and Related Disorders research?

By volume, the United States and China publish the most (969 and 363 works in 2022-now).

By volume, 2022-now

  1. 1 United States 969 works
  2. 2 China 363 works
  3. 3 Japan 255 works
  4. 4 India 195 works
  5. 5 United Kingdom 139 works
  6. 6 Spain 121 works
  7. 7 Italy 106 works
  8. 8 Germany 105 works
  9. 9 Türkiye 87 works
  10. 10 South Korea 83 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 40.0%China: 15.0%Japan: 10.5%India: 8.1%6 others listed: 26.5%40%largest
United States969 · 40.0%China363 · 15.0%Japan255 · 10.5%India195 · 8.1%6 others listed642 · 26.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Potassium and Related Disorders research?

By volume in 2022-now, Harvard University publishes the most Potassium and Related Disorders research, followed by AstraZeneca (United Kingdom) and Mayo Clinic.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 27 works
  2. 2 AstraZeneca (United Kingdom)United Kingdom 25 works
  3. 3 Mayo ClinicUnited States 24 works
  4. 4 United States Department of Veterans AffairsUnited States 20 works
  5. 5 Yale UniversityUnited States 13 works
  6. 6 Rutgers, The State University of New JerseyUnited States 13 works
  7. 7 Johns Hopkins UniversityUnited States 13 works
  8. 8 Peking UniversityChina 13 works
  9. 9 Sichuan UniversityChina 12 works
  10. 10 Karolinska InstitutetSweden 12 works

Who are the leading researchers in Potassium and Related Disorders?

The most-cited researchers publishing on Potassium and Related Disorders include Walter Churchill Willett, John J.V. McMurray and Hermann Brenner.

  1. 1 Walter Churchill Willett United States 411k citations
  2. 2 John J.V. McMurray United Kingdom 349k citations
  3. 3 Hermann Brenner Germany 343k citations
  4. 4 Cyrus Cooper United Kingdom 342k citations
  5. 5 Giuseppe Remuzzi Italy 328k citations
  6. 6 Gregory Y.H. Lip United Kingdom 311k citations
  7. 7 Salim Yusuf Canada 294k citations
  8. 8 Stuart Pocock United Kingdom 273k citations
  9. 9 Josef Coresh United States 272k citations
  10. 10 Marcello A. Tonelli Canada 268k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Potassium and Related Disorders?

The most cited paper in Potassium and Related Disorders is "Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study" (Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al., 2017), with 29,690 citations. Next come "Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy" (6,216) and "Natriuretic Peptides" (1,937).

Most cited papers
#PaperReleasedCitations
1 Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al. · Kidney & Blood Pressure Research Open access 2017 29,690
2 Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Vlado Perkovic et al. · New England Journal of Medicine Open access 14 Apr 2019 6,216
3 Natriuretic Peptides Franklin H. Epstein, Ellis Robert Levin, David G. Gardner et al. · New England Journal of Medicine 30 Jul 1998 1,937
4 Cardiorenal Syndrome Claudio Ronco, Mikko Haapio, Andrew A. House et al. · Journal of the American College of Cardiology Open access 29 Oct 2008 1,883
5 Chronic Kidney Disease Diagnosis and Management Teresa K. Chen, Daphne H. Knicely, Morgan Erika Grams · JAMA Oct 2019 1,816
All 100 most cited papers, with filters and sorting

Where is Potassium and Related Disorders research done?

The largest centres of Potassium and Related Disorders research in 2022-now are Tokyo (Japan), Beijing (China), Seoul (South Korea) and New York (United States).

Largest cities, 2022-now

  1. 1 TokyoJapan 60 works
  2. 2 BeijingChina 57 works
  3. 3 SeoulSouth Korea 45 works
  4. 4 New YorkUnited States 39 works
  5. 5 MadridSpain 36 works
  6. 6 LondonUnited Kingdom 35 works
  7. 7 BostonUnited States 32 works
  8. 8 ShanghaiChina 28 works
  9. 9 Mexico CityMexico 27 works
  10. 10 GuangzhouChina 26 works
See Potassium and Related Disorders on the map

Where is the best place to study Potassium and Related Disorders?

Among universities, judged by research, Harvard University, Karolinska Institutet and Baylor College of Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 18.18%fractional works in this field (log) →share of work in the world top 10% →University of TorontoHarvard UniversityBaylor College of Me…Karolinska Institutet
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 82.422.4%2.7×27 -0.4%
2Karolinska InstitutetSweden 63.512.5%6.7×12 +17.5%
3Baylor College of MedicineUnited States 57.517.8%6.4×10 +21.5%
4University of TorontoCanada 55.422.8%1.7×11 -6.0%
5Yale UniversityUnited States 55.112.2%3.9×13 +41.9%
6Johns Hopkins UniversityUnited States 54.813.0%2.7×13 -12.1%
7University of California, Los AngelesUnited States 52.414.6%3.2×12 +33.3%
8Sun Yat-sen UniversityChina 52.026.6%1.2×8 +36.9%
9Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 51.821.2%2.9×10 +106.3%
10Sichuan UniversityChina 50.418.7%1.7×12 +133.6%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Potassium and Related Disorders, country by country

Is Potassium and Related Disorders research growing?

Output in 2022-2025 was 20% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Potassium and Related Disorders.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Potassium and Related Disorders as a percentage of every work published that year, 0.014% in 2024.

still counting0.010%0.020%0.030%Potassium and Related Disorders0.015% in 202519801990200020102020

Fractional works of Potassium and Related Disorders over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Potassium and Related Disorders10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Potassium and Related Disorders. Posts are plain text and can be reported.